Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

impe0096p35 | Bone, Growth Plate and Mineral Metabolism | IMPE2023

Patient with cutaneous skeletal hypophosphatemia syndrome treated with Burosumab (monoclonal FGF23 antibody)

Viterbo Gisela , del Pino Mariana , Agustina Valentini María , La Forgia Pablo , Salvatierra Roberto , Belleri Florencia , Abbate Silvina , Chinton Josefina , Manuel Lazzati Juan , Betina Cervini Andrea , Fano Virginia

Introduction: Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a mosaic RASopathy caused by postzygotic activating mutations in HRAS, NRAS or KRAS. It is characterised by the presence of congenital epidermal, melanocytic, or sebaceous nevi, elevated circulating FGF23 levels that causes renal phosphate wasting and rickets, skeletal hypomineralization and focal bone lesions ipsilateral to nevi.Clinical Case: We repor...

impe0096p90 | GH and IGFs | IMPE2023

Proposed criteria to guide the molecular study of the IGF-1 receptor gene (IGF1R)

Plomer Paula , Celeste Mattone María , Perez Garrido Natalia , César Ramirez Pablo , Marino Roxana , Manuel Lazzati Juan , Guercio Gabriela , Ciaccio Marta , Isabel Di Palma María

Background: The role of Insulin-Like Growth Factor 1 (IGF1) in pre- and postnatal growth and brain development is widely recognized. It binds and activates its transmembrane receptor encoded by the IGF1R gene (15q26.3). Defects of IGF1R produces IGF1 resistance, characterized by pre- and postnatal growth retardation, microcephaly, and normal/elevated IGF1 serum levels, with great phenotypic variability.Aim: To e...

impe0096p153 | Thyroid | IMPE2023

Establishment and verification of pediatric thyrotrophin and thyroid hormones reference intervals using indirect methods.

Ethel Zaidman Veronica , Chaler Eduardo , Dujovne Noelia , Gazek Natalia , Pelanda Melina , Garin Gomez Sabrina , Lopez Micaela , Ciaccio Marta , Manuel Lazzati Juan

Introduction and aim: Establishing reference intervals (RI) is particularly problematic for constituents with a large diversity of existing biological variation and inter-population differences, as is observed for thyroid hormones and TSH. An alternative to this problem is to use indirect methods, with a large data pools base of results. Analyze thousands of subjects including some pathologic results is statistically stronger than 120 subjects that assume heal...

impe0096ep4 | Adrenals and HPA Axis | IMPE2023

Infant with primary hypoaldosteronism due to aldosterone synthase deficiency

Viterbo Gisela , Ciaccio Marta , Martinez Castillo Iratxe , Sabbarese Luciana , Florencia Soto María , Manuel Lazzati Juan , Perez Garrido Natalia , Marino Roxana , Costanzo Mariana

Background: Aldosterone synthase is a cytochrome P450 enzyme encoded by the CYP11B2 gene and responsible of the conversion of dehydrocorticosterone to aldosterone through three enzymatic steps: addition of the 11b-hydroxyl group to form corticosterone, 18-hydroxylation to form 18-hydroxycorticosterone, and 18-dehydrogenation to form aldosterone. Two types of aldosterone synthase deficiency have been reported: type I related to defects in 18-hydroxilation, and ...

impe0096p10 | Adrenals and HPA Axis | IMPE2023

Cortisol response in Non-Classic Congenital Adrenal Hyperplasia

Victoria Lobo de la Vega María , Celeste Mattone María , Marino Roxana , Manuel Lazzati Juan , Zaidman Verónica , Perez Garrido Natalia , Pelanda Melina , Balbi Viviana , César Ramírez Pablo , Belgorosky Alicia , Ciaccio Marta , Guercio Gabriela , Costanzo Mariana

Background: Non-classic forms of Congenital Adrenal hyperplasia (NCCAH) due to 21-hydroxylase deficiency are usually associated with variable degrees of postnatal androgen excess but adequate cortisol and aldosterone production. However, few studies have evaluated cortisol response.Aim: to describe the clinical, biochemical characteristics, and cortisol response to Corticotropin test in a cohort of patients with NCCAH st...

impe0096fc3.1 | Endocrinology of Sex Differences 1 | IMPE2023

Characterization and follow-up of a cohort of thirty patients with 46,XX testicular/ovotesticular disorders of sexual development

Celeste Mattone María , Berensztein Esperanza , Marino Roxana , Sol Touzón María , Marcela Bailez María , Nielsen Vanina , Weller Santiago , Laura Galluzzo Mutti María , Manuel Lazzati Juan , Belén Martinez María , Bulgach Valeria , César Ramírez Pablo , Pérez Garrido Natalia , Ciaccio Marta , Belgorosky Alicia , Guercio Gabriela , Costanzo Mariana

Background: 46,XX testicular/ovotesticular disorders of sexual development (T/OT DSD) are infrequent congenital conditions characterized by the presence of functional ovarian and testicular parenchyma or only testicular tissue in 46,XX individuals. Affected subjects present with different degrees of virilization of the external genitalia and development of Müllerian and Wolffian derivatives. Our knowledge about these conditions has been enlightened with t...